Yuan Tu

Chongqing Key Laboratory Of Maternal And Fetal Medicine
Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer: A Multi-Center Retrospective Study.

A Novel Nomogram Incorporating the Aggregate Index of Systemic Inflammation, Clinicopathological Parameters and Molecular Classification to Predict Recurrence of Endometrial Cancer: A Multi-Center Retrospective Study.

Journal: Cancer medicine

Published: November 04, 2025

The prognostic significance of JAML and its role in remodeling the immune microenvironment via the cGAS-STING pathway in endometrial cancer.

The prognostic significance of JAML and its role in remodeling the immune microenvironment via the cGAS-STING pathway in endometrial cancer.

Journal: Frontiers in immunology

Published: November 03, 2025

Predictive value of IGF2BP2 for endometrial cancer recurrence: a multicenter study.

Predictive value of IGF2BP2 for endometrial cancer recurrence: a multicenter study.

Journal: Frontiers in oncology

Published: October 27, 2025

Nomogram Based on Pan-Immune Inflammation Value and Clinicopathological Parameters for Predicting the Recurrence of Endometrial Cancer and Providing Postoperative Prognostic Management.

Nomogram Based on Pan-Immune Inflammation Value and Clinicopathological Parameters for Predicting the Recurrence of Endometrial Cancer and Providing Postoperative Prognostic Management.

Journal: Annals of surgical oncology

Published: June 03, 2025

Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study.

Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study.

Journal: Journal of inflammation research

Published: March 29, 2025

Prognostic significance and immune infiltration analysis of HMGA2 in endometrial cancer.

Prognostic significance and immune infiltration analysis of HMGA2 in endometrial cancer.

Journal: Frontiers in immunology

Published: January 12, 2025

Consistency of P53 immunohistochemical expression between preoperative biopsy and final surgical specimens of endometrial cancer.

Consistency of P53 immunohistochemical expression between preoperative biopsy and final surgical specimens of endometrial cancer.

Journal: Frontiers in oncology

Published: June 15, 2023

Incidence, risk factors, and a prognostic nomogram for distant metastasis in endometrial cancer: A SEER-based study.

Incidence, risk factors, and a prognostic nomogram for distant metastasis in endometrial cancer: A SEER-based study.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: June 03, 2023

Prognostic Value of the Cutoffs for HALP in Endometrial Cancer.

Prognostic Value of the Cutoffs for HALP in Endometrial Cancer.

Journal: American journal of clinical oncology

Published: January 26, 2023

YAP1 affects the prognosis through the regulation of stemness in endometrial cancer.

YAP1 affects the prognosis through the regulation of stemness in endometrial cancer.

Journal: PeerJ

Published: January 23, 2023

Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer.

Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer.

Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research

Published: December 15, 2022

Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.

Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.

Journal: The International journal of biological markers

Published: October 17, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026